Evaluation of Laboratory Findings for Treating Acute Ischemic Stroke
-
Published:2023-04-26
Issue:1
Volume:2
Page:8-12
-
ISSN:2822-4078
-
Container-title:Global Emergency and Critical Care
-
language:
-
Short-container-title:globecc
Author:
Keskinbalta DilaraORCID, Öztürk DeryaORCID, Melekoğlu AdemORCID, Uysal EnderORCID, Altınbilek ErtuğrulORCID
Publisher
Galenos Yayinevi
Reference27 articles.
1. Major biochemical constituents of Withania somnifera (ashwagandha) extract: A review of chemical analysis;Abdelwahed;Reviews in Analytical Chemistry,2023 2. Afewerky, H. K., Ayodeji, A. E., Tiamiyu, B. B., Orege, J. I., Okeke, E. S., Oyejobi, A. O., ... & Adeyemi, S. B. (2021). Critical review of the Withania somnifera (L.) Dunal: ethnobotany, pharmacological efficacy, and commercialization significance in Africa. Bulletin of the National Research Centre, 45, 1-16. 3. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats;Ahmad;Human & experimental toxicology,2005 4. Alanazi, H. H., & Elfaki, E. (2023). The immunomodulatory role of Withania somnifera (L.) dunal in inflammatory diseases. Frontiers in Pharmacology, 14, 430. 5. Anwar, F., Muhammad, G., Hussain, M. A., Zengin, G., Alkharfy, K. M., Ashraf, M., & Gilani, A. H. (2016). Capparis spinosa L.: A plant with high potential for development of functional foods and nutraceuticals/pharmaceuticals. International Journal of Pharmacology, 12(3), 201-219.
|
|